TrialWorld journal of gastroenterology2004

Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.

Ming Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.